Substitute House Bill No. 6855, also known as Public Act No. 25-101, introduces significant regulatory changes regarding the sale of hemp flower and the operation of nonresident pharmacies in Connecticut. Effective October 1, 2025, the bill permits individuals not licensed as cannabis establishments or moderate-THC hemp product vendors to sell hemp flower, provided they meet specific conditions such as in-person assistance and age verification for purchasers. The bill also revises definitions related to cannabis and hemp regulation to align with existing statutes. For nonresident pharmacies, effective January 1, 2026, the bill modifies reporting requirements by replacing "A nonresident pharmacy shall file" with "File" and mandates the submission of inspection reports from government agencies or qualified third-party entities to demonstrate compliance with health standards.

Additionally, the bill amends the classification of marijuana under Connecticut's controlled substance regulations, designating it as a schedule II controlled substance and allowing for the introduction of new controlled substances. It also updates the process for issuing written certifications for the palliative use of marijuana by healthcare professionals, allowing for temporary extensions and telehealth services. The bill clarifies the definition of "Backer" to exclude certain financial institutions and individuals with limited investment interests, streamlines regulations for cannabis establishments, and introduces new requirements for the sale of moderate-THC hemp products, including age verification and adherence to testing standards. Overall, the bill aims to enhance consumer protection, ensure compliance with health standards, and streamline the regulatory framework for cannabis and hemp products in Connecticut.

Statutes affected:
Raised Bill: 20-627
GL Joint Favorable Substitute: 20-627
File No. 618: 20-627
Public Act No. 25-101: 20-627